Fibroblast growth factor 21 proteins
US8741841B2 · kind B2 · utility
37Cited by
0References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jun 5, 2013 |
| Grant date | Jun 3, 2014 |
| Priority date | — |
| Expiry date | Jun 5, 2033 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2319/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This present invention relates to pharmacologically potent and stable human fibroblast growth factor 21 (FGF21) proteins, pharmaceutical compositions comprising FGF21 proteins, and methods for treating type 2 diabetes, obesity, dyslipidemia, and/or metabolic syndrome using such proteins.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.